| Company Name | Astellas Pharma Taiwan, Inc. |
|---|---|
| Protocol Number | HAURO-0605-TW |
| Title of Study | An open-label, randomized, parallel study to evaluate the clinical efficacy and safety of tamsulosin alone or in combination with solifenacin for the treatment in men with lower urinary tract symptoms including overactive bladder symptoms |
| Primary Objective | 1. Evaluate the clinical efficacy of tamsulosin alone or in combination with solifenacin for the treatment in men with lower urinary tract symptoms including overactive bladder symptoms in Taiwan 2. Evaluate the safety of tamsulosin alone or in combination with solifenacin for the treatment in men with lower urinary tract symptoms including overactive bladder symptoms in Taiwan |
| Number of Sites | 1 |
| Period of Study | From：September 2007 to：April 2011 |
| Number of Patients | 52人 |
| IRB Approval Date | 01 June 2007 |
| Publication Plan / Date | TBC |
